This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Browse

Uridine Monophosphate (UMP)

Moderately Studied

Pyrimidine nucleoside | CDP-choline pathway substrate — feeds the Kennedy pathway as the rate-limiting cytidine donor for synaptic membrane phosphatide synthesis. Wurtman MIT lab paradigm: uridine + omega-3 (DHA) + choline = synaptogenesis substrate triad.

Aliases (7)
UMP · uridine-5′-monophosphate · uridine · disodium UMP · triacetyluridine · TAU · PrL-8-53 (different — PRL-8-53 is a separate compound)
TYPICAL DOSE
150-500 mg/day
Daily AM
ROUTE
Oral (capsule, sublingual)
Oral capsule or sublingual TAU
CYCLE
Continuous
Continuous; reassess at 12 weeks
STORAGE
Room temp; cool, dry, dark
Cool, dry, dark

Overview

What is Uridine Monophosphate (UMP)?

Uridine monophosphate (UMP) is a pyrimidine ribonucleotide — uracil base + ribose + 5'-phosphate. It is endogenous (the body synthesizes it de novo and salvages it) and present in dietary RNA-rich foods (organ meats, beer, breast milk). As an OTC supplement it's sold as the disodium salt (oral capsule, 150-500 mg) or as triacetyluridine (TAU, sublingual, 25-50 mg) — a lipophilic prodrug with higher CNS bioavailability. Not FDA-approved as a drug; widely available as a dietary supplement.

Key Benefits

Substrate for the CDP-choline / Kennedy pathway — the route brain neurons use to build phosphatidylcholine and other membrane phospholipids. Pairs with DHA + choline (the Wurtman MIT triad) to support synaptogenesis and synaptic protein expression (PSD-95, synapsin-1). Used in the Souvenaid/Fortasyn Connect formulation for prodromal Alzheimer's. Community use cases: mood support, cognitive baseline, racetam stack adjunct, BDNF-pathway support.

Mechanism of Action

Oral UMP is dephosphorylated in the gut to uridine (which crosses the blood-brain barrier via SLC28/SLC29 nucleoside transporters); brain uridine kinase converts it back to UMP, then UDP, then CTP. CTP combines with phosphocholine to form CDP-choline — the rate-limiting intermediate in the Kennedy pathway for phosphatidylcholine synthesis. With DHA providing the fatty-acid tail and choline the head-group, uridine supplies the cytidine donor that lets neurons assemble new synaptic membrane. Half-life of plasma uridine after oral UMP is ~2 hours; once-daily dosing maintains adequate substrate for chronic synaptogenic support.

Pharmacokinetics

·
PeakHalf-life
Approximate curve — visual aid only, not data-precise PK

Peptide Interactions

Fish oil (DHA / EPA):
Synergistic

✅ The canonical Wurtman pairing. DHA is the fatty-acid tail; uridine is the cytidine donor. Inseparable for the synaptogenesis use case. DHA 1-2 g/day + UMP …

Citicoline (CDP-choline):
Synergistic

✅ Citicoline already supplies cytidine + choline + phosphate (it IS reassembled CDP-choline). Adding UMP further raises plasma uridine. Modest redundancy, no…

Alpha-GPC:
Synergistic

✅ Alpha-GPC supplies the choline arm; UMP supplies the cytidine arm; together with DHA → full Kennedy substrate triad. Stack-friendly when alpha-GPC is the c…

Racetams (piracetam, aniracetam, oxiracetam, phenylpiracetam):
Synergistic

✅ Racetams modulate AMPA + cholinergic transmission and reportedly consume choline faster (the "racetam headache"). UMP + choline + DHA provides membrane-pho…

Magnesium L-threonate:
Synergistic

✅ Threonate's NMDA / synaptic-plasticity profile is mechanistically complementary. No conflict.

Phosphatidylserine (PS):
Synergistic

✅ Both feed membrane-phospholipid pool from different angles (intact phosphatide vs precursor). Common combo in cognitive-decline protocols.

L-tyrosine:
Synergistic

✅ Catecholamine substrate vs membrane-phosphatide substrate — orthogonal. Stack-safe.

5-Fluorouracil (5-FU) / capecitabine chemotherapy:
Avoid

❌ Uridine antagonizes 5-FU. Vistogard (uridine triacetate) is FDA-approved as an emergency 5-FU overdose antidote specifically because uridine outcompetes 5-…

Quality Indicators

Disodium UMP form clearly labeled

Most reputable products (Nootropics Depot, Jarrow, Liftmode) specify 'uridine-5'-monophosphate disodium' on the label. The disodium salt is the standard pharmacology-grade form; ambiguous 'uridine' labels may be the free nucleoside (less stable, lower bioavailability).

Third-party COA available

Reputable nootropics vendors publish Certificates of Analysis confirming identity (HPLC), purity (>98%), and contaminant testing (heavy metals, microbial). Demand this for any nucleotide supplement.

Sublingual TAU clearly distinguished from oral UMP

Triacetyluridine (TAU) is a lipophilic prodrug used sublingually at much lower doses (25-50 mg) than oral UMP (150-500 mg). A label conflating the two is a quality-control flag.

!

Powder hygroscopicity

UMP disodium is hygroscopic — bulk powder clumps in humid conditions. Store in airtight container with desiccant; weigh by mass not volume. Capsule form sidesteps this.

Proprietary 'uridine complex' blends

Avoid products that hide UMP dose inside a proprietary blend with vague 'phosphatide complex' marketing. The Wurtman triad only works at adequate UMP dose; underdosed blends are common.

No origin or batch information

Anonymous bulk-powder vendors without batch numbers, COAs, or sourcing documentation carry adulteration risk. UMP itself is cheap to manufacture — the cost is in QC, not raw material.

What to Expect

  • Onset
    over days to weeks, not minutes. Most users feel nothing acutely.
  • Onset
    30-60 min sublingual; duration 4-6 hr.

Side Effects & Safety 5

Side Effects

  1. 1Mostly nothing. Uridine is exceptionally well-tolerated at supplement doses.
  2. 2Mild GI discomfort (occasional nausea, loose stool) on empty stomach — take with food.
  3. 3Mild headache (uncommon; usually first week, fades)
  4. 4Vivid dreams (chronic dosing, especially when stacked with choline)
  5. 5Mild "flat" mood in a small subset of chronic users (possibly the same cholinergic-overshoot pattern that affects high-dose alpha-GPC users)

When to Stop

  • Mood destabilization (hypomania, irritability) in bipolar-spectrum users — flagged in the Kondo 2011 trial population but no clean signal at supplement doses.
  • 5-FU / capecitabine antagonism: uridine outcompetes 5-FU at thymidylate synthase. Therapeutically used as Vistogard (FDA-approved 5-FU overdose antidote). Active 5-FU/capecitabine chemo patients should pause uridine supplementation — coordinate with oncology.
  • Theoretical purine/pyrimidine handling concerns in gout / hyperuricemia patients on allopurinol. No clinical signal but worth flagging.
  • First 1-2 weeks: GI tolerance, headache. If headache severe → reduce dose or pause.
  • Week 4-8: mood/affect monitoring (rare cholinergic-overshoot pattern when stacked with choline).
  • Long-term (>6 months): no documented safety concerns; uridine is endogenous and salvaged by normal metabolism.

References

Wurtman RJ, Cansev M, Sakamoto T, Ulus IH 2009, Annu Rev Nutr — Use of phosphatide precursors to promote synaptogenesis

pubmed.ncbi.nlm.nih.gov · 2009

PMID 19400698. Foundational MIT-lab review establishing the uridine + DHA + choline triad.

View Study

Sakamoto T, Cansev M, Wurtman RJ 2009, Brain Res — Oral supplementation with DHA and UMP increases dendritic spine density in adult gerbil hippocampus

pubmed.ncbi.nlm.nih.gov · 2009

PMID 19262950.

View Study

Carlezon WA Jr et al. 2005, Biol Psychiatry — Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats

pubmed.ncbi.nlm.nih.gov · 2005

PMID 15705349. Keystone rat forced-swim study.

View Study

Soininen H et al. 2017, Lancet Neurol — 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet)

pubmed.ncbi.nlm.nih.gov · 2017

PMID 29097166. n=311; CDR-SoB benefit, primary cognitive composite negative.

View Study

Soininen H et al. 2021, Alzheimer's Dement — 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease

pubmed.ncbi.nlm.nih.gov · 2021

PMID 32920957. Extended follow-up.

View Study
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources